In reply to a question in the Rajya Sabha on National Human Rights Commisssion notice on illegal drug trials in three government hospitals in Delhi, Minister of Health and Family Welfare Ghulam Nabi Azad said his Ministry has sent its reply on March 11 after the matter was examined by three expert committees.
The NHRC had sent the notice on February 7 this year over alleged illegal clinical trials on 3,479 children during the last five years in Delhi's three government hospitals - Safdarjung Hospital, Lok Nayak Jaya Prakash Narayan Hospital and Kalawati Saran Hospital.
"On the basis of the report of these committees, the DCG (I), in its report to the Ministry, concluded that the studies at these hospitals were conducted on the children after taking the consent of their guardians/parents. However, in case of Safdarjung Hospital, a few flaws were noted in getting their informed consent," Azad said.
The Health Ministry will ensure that all required measures are taken by DCG(I) "so that only those clinical trials are allowed in future which are strictly as per prescribed norms", the Minister assured the House.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
